Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
15.5%
% of WDNA's 90 holdings also in PBE
46.4%
% of PBE's 28 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.7% | 5.4% | 3.7% |
|
BLUEPRINT MEDICINES CORP. | 2.6% | 2.9% | 2.6% |
|
VERACYTE INC | 2.1% | 2.9% | 2.1% |
|
GILEAD SCIENCES INC | 1.9% | 5.3% | 1.9% |
|
UNITED THERAPEUTICS CORP | 1.7% | 4.5% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to PBE
|
TWIST BIOSCIENCE CORP. | 3.3% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
VERICEL CORPORATION | 2.6% |
|
BRIDGEBIO PHARMA, INC. | 2.4% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
 |
NOVARTIS AG | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% |
|
BRISTOL-MYERS SQUIBB CO | 1.5% |
WDNA Underweight Relative to PBE
|
NEUROCRINE BIOSCIENCES INC | -4.9% |
|
PROTAGONIST THERAPEUTICS, INC. | -4.1% |
|
TG THERAPEUTICS INC | -4.0% |
|
BIOGEN IDEC INC | -4.0% |
|
ILLUMINA INC | -3.5% |
|
GILEAD SCIENCES INC | -3.4% |
|
CATALYST PHARMACEUTICAL PART | -3.3% |
|
AMGEN INC | -3.3% |
|
REGENERON PHARMACEUTICALS | -3.2% |
|
HALOZYME THERAPEUTICS INC | -3.1% |